Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
113M
-
Shares change
-
+7.36M
-
Total reported value, excl. options
-
$961M
-
Value change
-
+$78.2M
-
Put/Call ratio
-
1.34
-
Number of buys
-
76
-
Number of sells
-
-46
-
Price
-
$8.50
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q3 2024
159 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q3 2024.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 113M shares
of 144M outstanding shares and own 78.47% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (10.5M shares), MORGAN STANLEY (9.9M shares), VR Adviser, LLC (9.83M shares), PERCEPTIVE ADVISORS LLC (8.01M shares), BlackRock, Inc. (6.94M shares), FRANKLIN RESOURCES INC (6.8M shares), Propel Bio Management, LLC (6.57M shares), Knoll Capital Management, LLC (5.57M shares), VANGUARD GROUP INC (5.24M shares), and DEUTSCHE BANK AG\ (4.44M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.